Financial insights of HROW

MyFinsight

For the quarter ending 2025-09-30, HROW made $71,638K in revenue. $1,020K in net income. Net profit margin of 1.42%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenues	71,638	63,742	47,831	49,257
Cost of sales	17,712	16,230	15,524	12,018
Gross profit	53,926	47,512	32,307	37,239
Selling, general and administrative	35,856	33,235	40,513	33,645
Research and development	3,323	2,868	3,026	2,273
Total operating expenses	39,179	36,103	43,539	35,918
Income (loss) from operations	14,747	11,409	-11,232	1,321
Interest expense, net	6,038	6,408	6,548	5,525
Loss on extinguishment of debt	-7,750	-	-	-
Investment loss from eton pharmaceuticals	-	0	-	-
Other income, net	61	-6	-	4
Total other expense, net	-13,727	-6,414	-6,548	-5,521
Income (loss) before income taxes	1,020	4,995	-	-4,200
Income tax expense	-	0	-	20
Net income (loss)	1,020	4,995	-17,780	-4,220

Basic net income (loss) per share of common stock	0.03	0.14	-0.5	-0.12
Diluted net income (loss) per share of common stock	0.03	0.13	-0.5	-0.12
Weighted average number of shares of common stock outstanding, basic	37,145,440	36,790,306	35,826,452	35,702,200
Weighted average number of shares of common stock outstanding, diluted	38,875,005	38,853,855	35,826,452	35,702,200